Placing ovarian tissue strips into the preserving solution<unk>  is a subfield that bridges oncology and reproductive research to explore and expand options for the reproductive future of cancer survivors. The name was coined in 2006 by Teresa K. Woodruff at the<unk>  Consortium. Cancer treatments, such as chemotherapy, radiation, and surgery, may destroy a person's ability to have children later in life, and<unk>  research focuses on increasing fertility preservation options. With 10% of cancer patients being younger than age 40, this issue affects more than 135,000 people in the United States each year. As cancer survivorship increases, the preservation of fertility in women, men, and children becomes a critically important topic to patients and their families. The ability to easily preserve fertility prior to cancer treatment can provide hope at the time of diagnosis for families later in life.<unk>  also incorporates reproductive issues after cancer treatment, such as family planning, complex contraception, hormonal management throughout survivorship, surrogacy, and adoption.
Oncofertility
Infertility
Male infertility
Ejaculation disorders
Menometrorrhagia
Hypomenorrhea
Prognathism
Female infertility